Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which allergy skin prick test hurts least and works best?

NCT ID NCT07400718

Diagnosis Sponsor: QHSLab, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared three FDA-cleared allergy skin test devices (AllerTest-10, Lincoln Multi-Test II, and Greer Skintestor OMNI) in 30 adults to see which is most accurate and least painful. Participants received histamine and glycerin controls on their skin, and researchers measured wheal size and pain scores. The goal is to help doctors pick the best tool for diagnosing allergies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose the most reliable and least painful skin test for diagnosing allergies.
What could go wrong
This is a small, completed comparison study with only 30 participants, so results may not apply to everyone. It does not test new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Nov 2025

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients will be entered into this study only if they meet all of the following criteria: 1. Written and signed informed consent obtained before starting any protocol-specific procedures. 2. Subjects willing to withhold antihistamines, Leukotriene antagonists and H2 antagonists for at least 1 week before testing to avoid masking the histamine reactions on the skin. 3. Male or female between 18 to 60 65 years, inclusive. 4. Ability to comply with the study procedures and visit schedule. Exclusion Criteria: * Patients will NOT be entered into this study if they meet any of the following criteria: 1. Anaphylactic reaction (constitutional) after the previous skin test with the same allergen 2. Acute fever 3. Systemic disease with acute manifestation or decompensation 4. Abnormal skin condition in the area to be tested (such as eczema sunburn condition after sunbathing) 5. Pregnancy 6. Presence of dermatographism, severe atopic dermatitis, or use of tricyclic antidepressants. 7. Current use of beta-blockers 8. Known hypersensitivity to any component of the test solutions (histamine or glycerin). 9. Participation in another clinical study within 30 days before enrollment. Participation in another clinical study within 30 days before enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Allergy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

allergic disease food allergy Hypersensitivity, Immediate IgE responsiveness, atopic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Allergy Hypersensitivity, immediate Ig-E mediated food

Contacts and locations

Locations

  • QHS Health center

    Miami, Florida, 33155, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.